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The pregnancy-specific glycoprotein (PSG) genes encode a group of proteins which are found in 
large amounts in placenta and maternal serum. In situ hybridization analyses of metaphase 
chromosomes reveal that all the human pregnancy-specific glycoprotein (PSG) genes are located 
on the long arm of chromosome 19 (19q13.2-13.3), overlapping the region containing the 
closely-related carcinoembryonic antigen (CEA) gene subgroup. Higher resolution analyses indicate 
that the PSG genes are closely linked within an 800kb Sac11 restriction endonuclease fragment. 
This has been confirmed through restriction endonuclease mapping and DNA sequence analyses 
of isolated genomic clones, which show that at least some of these genes are located in very close 
proximity. Further, these studies have helped to identify a new member of the PSG gene sub- 
family (PSG7). DNA/RNA hybridization analyses, using gene-specific oligonucleotide probes based 
on published sequences, showed that five from six PSG genes tested are coordinately transcribed 
in the placenta. Due to the close proximity of these genes and their coordinated expression pattern, 
common transcriptional regulatory elements may exist. 0 1990 Academic Press, Inc. 
The pregnancy-specific 81 glycoproteins (PSG) consist of a heterogenous group of molecules (1) 
which are expressed in the placenta during pregnancy and in tumors of trophoblastic origin (2). 
At term pregnancy, the PSG molecules represent some of the major placental proteins (3). Their 
presence in choriocarcinomas has indicated their potential utility as tumor markers (2). Until 
recently, little was known about the structure and complexity of this protein family, and their 
function still remains unknown. At least three immunologically-crossreacting PSG species with 
differing molecular sizes have been isolated from human placenta (4). Through molecular ana- 
lyses of genomic and cDNA clones, ten separate PSG genes have been identified so far, and their 
coding regions could be deduced (4-14). Differential splicing of at least one gene has been report- 
ed, whereby four mRNA variants have been found, encoding proteins which differ only in their 
short C-terminal domain regions (4,5,9,11,14). This increases the potential number of PSG pro- 
teins to thirteen, assuming that all the transcripts are translated. Sequence comparisons reveal that 
these genes are homologous to those encoding the carcinoembryonic antigen (CEA) and related 
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molecules (15). The PSG/CEA gene family belongs to the immunoglobulin (Ig) superfamily (15,16). 
Basically, as derived from DNA sequence data, the proteins consist of one N-terminal Ig variable 
(IgV)-like, and a differing number of immunoglobulin constant (IgC)-like domains (17). Differ- 
ences can be found in the C-terminal domain regions, whereby the CEA-related proteins appear 
to be membrane-bound, either after post-translational modification through processing and the 
addition of a glycosyl phosphatidylinositol tail (l&22), or as an integral membrane protein (23,24). 
Most of the PSG molecules apparently lack a transmembrane region and their deduced primary 
structures indicate that they are secreted (4,5,8,9,11). 
The CEA-related genes are clustered on the long arm of chromosome 19 (25-27). In this paper 
we have determined the fine chromosomal location of the PSG genes. DNA/RNA hybridization 
investigations using presumed gene-specific oligonucleotides have been applied to study the 
transcriptional activity of individual genes. These basic studies should help us to learn more about 
the regulation of PSG gene expression, and pave the way for functional analyses of this important 
group of pregnancy-specific glycoproteins. 
MATERIALS AND METHODS 
In situ hybridization: Preparation of chromosomes and in situ hybridizations were carried out as described 
previously (27) using a 1026bp EcoRI/SstI restriction endonuclease fragment from XhsCGM3-1 (10) which 
contains the N-terminal domain exon, as a probe. After 3 weeks exposure at 4”C, the chromosomes were 
RBG-banded by the method of Perry and Wolff (29). 
Isolation of high molecular weight genomic DNA and pulsed field gel electrophoresis analyses: High molecular 
weight DNA was isolated from an Epstein Barr virus-immortalized, human lymphoblast cell line, L1164 (gift 
from G. Scherer, Institute of Human Genetics, Freiburg University, FRG) in agarose blocks according to the 
European Molecular Biology Laboratory (EMBL, Heidelberg, FRG) protocol. Pulsed field gel electrophore- 
sis of large restriction endonuclease fragments was carried out on a CHEF-type model (EMBL, Heidelberg, 
FRG), at 4 V/cm and a pulse time of 90s in a 0.8% agarose gel for 43h at 15°C as described by the manu- 
facturers, and the DNA was transferred to a charged nylon membrane (GeneScreen-Plus, DuPont, Bad 
Homburg, FRG) according to the manufacturer’s protocol. The membrane was hybridized with a probe con- 
taining the total coding region minus the 3’untranslated portion of the PSGla cDNA clone described else- 
where (11). The hybridization was carried out overnight at 42°C in 40% deionized formamide, 1M NaCl, 10% 
dextran sulphate, 1% SDS, lOO/.rg/ml denatured salmon sperm DNA. Final washes were performed at 62°C in 
0.1x SSPE (lx SSPE: 180mM NaCl, 1OmM NaH,PO,, 1mM EDTA pH 7.4), 0.1% SDS. 
Bacterial strains, human genomic libraries and cloning vectors: All work with recombinant DNA was carried 
out according to the German and Swiss safety regulations. A human leucocyte genomic library in XEMBL3 
(HL1006; Clontech, Palo Alto, USA) was amplified in E. coli 803. A human cosmid genomic library (gift from 
W. Lindenmaier, Gesellschaft filr Biotechnologische Forschung, Braunschweig, FRG), inserted in the vector 
pHC79-2cos/TK, was amplified in the ret A- E. coli strain ED8767. For subcloning of the insert DNA frag- 
ments, either Bluescript phagemid (Stratagene, San Diego, USA) was used in E. coli strains JM109 and 
RRlbMlS, or M13mp18/19 phage, which was amplified in E. coli strain JM107. 
Screening of the human genomic libraries: Various DNA fragments were radiolabelled (28), and used to screen 
the human genomic libraries (30). For the lambda library, recombinant bacteriophages were amplified and 
transferred to nitrocellulose filters (Schleicher and Schuell, Dassel, FRG) as described (31). Screening and 
plaque purification was carried out by using the radioactively-labelled cDNA insert of pSP,-i (8). Hybridization 
was carried out at 65°C in a solution containing 5x Denhardt’s, SOC(g/ml denatured salmon sperm DNA, 0.05% 
SDS and 6x SSC (lx SSC = 0.15M NaCl, 0.017M Na-citrate pH 7.0). Final washes were performed at 65°C using 
0.1x SSC. For the cosmid library, the original screening was carried out using a 1.4kb EcoRI restriction 
endonuclease fragment, covering the 3’untranslated region of the NCA cDNA clone 9 (32). Colony hybridiz- 
ation on nitrocellulose filters (30) was used to identify the cosmid clones. Pre-hybridization was carried out at 
42°C in 40% deionized formamide, 6x SSPE, Ix Denhardt’s, 0.5% SDS, lOO~g/ml denatured salmon sperm DNA 
for 2h. Hybridization was under the same conditions but in the absence of SDS. Final washes were performed 
at 65°C in 2x SSPE, 0.5% SDS. 
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Restriction endonuclease mapping: Lambda clones were mapped by restriction endonuclease digests aided by 
hybridization with the pSP,-i cDNA insert (8). Detailed mapping of clone XPSG6/7-1 was carried out using DNA 
fragments subcloned in Bluescript plasmids. The cosmid clones were mapped by linearizing with the restriction 
endonucleases, PvuI or NheI, which cut in the vector at a short distance to the left and right of the cloning site, 
respectively. The resulting fragments were then partially digested with different restriction endonucleases (EcoRI, 
SstI and BamHI), separated by gel electrophoresis in 0.5% agarose overnight at 1 V/cm (4°C) and transferred 
to charged nylon membranes prior to hybridization with oligonucleotide probes whose complementary sequences 
are located in the vector between the PvuI site (oligo cosl), or the NheI site (oligo cos2) and the cloning site. 
The oligonucleotides were as follows: 
oligo cosl 5’ TAGGCGTATCACGAGGCCCCG 3 
oligo cos2 5’ GGCGATGCTGTCGGAATGGACG 3 
Hybridization was carried out in 30% deionized formamide, 1M NaCl, 1% SDS, 10% dextran sulphate, lOO~g/ml 
denatured salmon sperm DNA at 10-1X below the theoretical melting temperature (33). Final washes were 
carried out in 2x SSPE, 0.5% SDS at 3-5°C below the theoretical melting temperatures. Size determination of 
the fragments hybridizing allowed the linear mapping of restriction endonuclease sites. Uncertainties arising from 
this method could be resolved by isolating specific DNA fragments, followed by digestion with a second 
restriction endonuclease and by agarose gel electrophoresis separation. This was accompanied by hybridization 
analyses with various DNA probes from the coding region of a PSGla cDNA clone (ll), which were labelled 
by random priming (28) and hybridized at 42°C in 40% deionized formamide, 1M NaCl, 1% SDS, 10% dextran 
sulphate, lOO~g/ml denatured salmon sperm DNA. Final washes were carried out in either 0.1x, or 2x SSPE, 
1% SDS at 65°C. The exact positions of the exon/intron borders were determined by DNA sequencing. 
Determination of DNA sequences: Subcloned restriction endonuclease DNA fragments in phage M13mp18/19 
and Bluescript phagemid were sequenced as single or double stranded templates by the 
dideoxy-chain-termination method (34), using universal, or internal oligonucleotide primers and a sequencing 
kit (United States Biochemicals). For comparison of the nucleotide and deduced amino acid sequences. the 
computer program “Align” (M.‘Trippel, Fieiburg, FRG and R. Friedrich, Giessen, FRG: unp&lished)‘was 
used. 
RNA analyses by blot hybridization: RNA was extracted from a placenta of the 31st week of pregnancy 
according to the method of Chomczynski and Sacchi (35), or from colon tumour according to Fiddes and 
Goodman (36), as described elsewhere (27). Poly(A) RNA was purified once over an oligo(dT) column and 
size separated on methylmercury hydroxide denaturing agarose gels as described (27). Gene-specific oligonucleo- 
tides which were complementary to corresponding mRNAs were synthesized, based on known DNA sequence 
data, from the N-terminal domains of different PSG genes (Table I). Hybridization was carried out in 20-30% 
deionized formamide, 1% SDS, 1M NaCl, 10% dextran sulphate, lOO~g/ml denatured salmon sperm DNA at 
lo-15°C below the theoretical melting temperatures (33). The final washes were performed in 2-6x SSPE at a 
temperature where only hybrids with none or maximally one mismatch are stable. 
Primer extension experiments: In order to determine the transcriptional start for two PSG genes, gene-specific 
oligonucleotides which are complementary to corresponding mRNA species were used to prime extension 
reactions. For PSGS, the oligonucleotide used was oligo PSGS (Table I). For comparison, we used an 
oligonucleotide from the S-untranslated region of PSGl (oligo PSGl-5’= SGATAAGCCTAGGATCCAGAA- 
CKT 3’), based on sequence data from a corresponding genomic clone (XPSflG-1: [lo], and unpublished data). 
For the annealing reaction, 5-long, S-end labelled oligonucleotide was mixed with 2.5pg poly(A) RNA iso- 
lated from a term placenta, in 10,Ul 5mM sodium phosphate buffer pH 7.0, 5mM EDTA. After 5 min 
denaturation at 9O”C, 0.4 1.11 2M NaCl was added and hybridization took place in separate reactions at 40, 45, 
50, 55 or 60°C for l-2h. After this time the mixtures were either allowed to cool slowly to room temperature, 
or were directly taken for the extension reaction. The hybridization mix was adjusted to 17.5mM Tris/Cl pH 8.3, 
4.3mM MgCl,, 1.75mM dithiothreitol, 3.5mM dNTP, lng/bl actinomycin D, 2U/pl RNasin (Atlanta, Heidelberg, 
FRG), O.SU/~l reverse transcriptase (Pharmacia, Freiburg, FRG), in 25~1 volume and incubated at 42°C for 
lh. Following a phenol extraction and ethanol precipitation, the extension products were denatured and loaded 
onto an 8M urea/6% polacrylamide DNA sequencing gel. 
Sl nuclease analyses: The transcriptional start of PSGl was independently determined using Sl nuclease 
mapping. A 1.7kb Sst I restriction endonuclease fragment from the PSfiG-1 clone described elsewhere (lo), 
containing the first exon from PSGl (data not shown), was subcloned in M13mp19. A single-stranded DNA 
fragment, which was complementary to the mRNA was synthesized from this template using the same 
“‘P-labelled primer oligonucleotide as for the primer extension experiment (see above). For this, the oligo- 
nucleotide was 5’ end-labelled with polynucleotide kinase and annealed to the single-stranded Ml3 subclone 
according to the Perkin Elmer Cetus GeneAmpW DNA amplification protocol, followed by extension with 
Taq-polymerase (Amersham, Braunschweig, FRG), at 72’C for 30 min. The extension product was tiested with 
Pst I, separated on a preparative 4% poTyacryl&nide/8.3M urea gel, and the rest&g 362nc fra”ment was 
purified by electroelution. The hybridization with poly(A) RNA from a term placenta (see above), and the Sl 
nuclease mapping was essentially according to Maniatis et al. (30). For digestion of single strands, the 
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DNA/RNA complex was incubated with 1000 U/ml nuclease Sl for 30 min at 18°C. Analysis of the 
double-stranded DNA/RNA complex was carried out on a DNA sequencing gel. 
RESULTS 
Chromosomal ocalization of the PSG genes: The results of the in situ hybridization analyses with 
metaphase chromosomes are shown in Figure 1. Utilizing published sequence data from the coding 
regions of the N-terminal domains (4,5,8-10) in the equation presented by Lathe (33) it is possible 
to predict that all the members of the PSG gene subgroup but not from the CEA subgroup, should 
cross-hybridize with the XhsCGM3-1 probe (10) used, which corresponds to the gene PSG6 (13) 
under the conditions applied. Therefore, it appears that all the genes belonging to the PSG 
gene-subgroup are clustered on the long arm of chromosome 19 (Figure 1A). Finer mapping of the 
grain distribution locates this gene cluster to 19q13.2-q13.3 (Figure 1B). Closer studies regarding 
their location were carried out by pulsed field gel electrophoresis analyses. In order to test the 
hybridization stringency conditions for PSG gene subgroup specificity, isolated cosmid clones, 
cosPSG4/5-1 and cosPSG4/5-2 (see below), as well as lambda clones XhsPSjIG-1 and XhsCGM3-1 
(lo), which, according to the newly proposed nomenclature system (13), contain the genes encoding 
PSG4, PSGS, PSGl (formerly named PSBG) and PSG6 (formerly named hsCGM3) respectively, 
were co-hybridized as positive controls. Cosmid clone cosCEA1 (data to be published) and lambda 
clones X39.2 (37) and XhsCGM2-1 (lo), which contain the CEA, NCA and hsCGM2 genes, respect- 
ively, were co-hybridized as negative controls. Under the stringency conditions shown, all the PSG 
genes were found to hybridize, whereas the negative controls did not (results not shown). A control 
for cross-hybridization with genes PSG2 (=PS/?G-E [9]), PSG3 (SPl [8]), and PSG8 (=CGM35 [7]) 
was not carried out, but the high sequence similarity of all the PSG genes would suggest that they 
too should be positive under the stringency conditions applied. It can, therefore, be concluded that 
the strong signal seen in the genomic analysis (Figure 2) probably represents all the PSG genes, 
which are localized within an 800kb Sac11 restriction endonuclease fragment. The weaker band at 
around 980kb represents the region of limited mobility for large DNA fragments. This could 
contain incompletely digested DNA fragments, although it cannot be ruled out that a small number 
of PSG genes are located on at least one other, larger DNA fragment. 
B 
19 
FIG. (A) In Situ hybridization with a genomic PSG6 probe (see text). The histogram shows the grain 
distribution in metaphase chromosomes indicating that all PSG genes are located on chromosome 19. (B) Finer 
mapping of grain distribution over chromosome 19 localizes the PSG gene subfamily to the long arm at positions 
19q13.2-q13.3. 
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FIG.L. Pulsed field gel electrophoresis analysis of human lymphoblast cell line L1164 DNA, digested with Sac11 
and hybridized with the total coding region of a PSGla cDNA clone (see text) under conditions whereby all PSG 
genes should hybridize. Calibration at the right was achieved by inclusion of Saccharomyces ceretisiae 
chromosomes as length markers. 
Fine structural analyses of cloned PSG genes: In order to study the gene linkage more exactly, 
we started to screen a cosmid library by chromosome walking, so as to determine how close 
neighbouring PSG genes are. The two cosmid clones cosPSG4/5-1 and cosPSG4/5-2 were chosen 
for closer analyses because they revealed very similar restriction endonuclease fragment sizes for 
a given enzyme, as well as similar hybridization patterns with a number of different DNA probes 
(results not shown), indicating that they represent two overlapping clones, and thus, provide a 
better chance for finding linkage than analysing single clones. Furthermore, one of these clones 
(cosPSG4/5-1, adopting the new nomenclature system [13]) has already been shown to contain the 
N-terminal domain exon for a member of the PSG gene subgroup (lo), where it was formerly 
named cosmid hsCGM4-1. Restriction endonuclease mapping, along with hybridization analyses 
and DNA sequencing was carried out for these different clones in order to determine the 
exon/intron structures and the identity of the genes contained therein (Figure 3B). It could be 
confirmed that the two cosmid clones overlap through DNA sequencing. Together these clones 
contain the entire coding regions of two PSG genes, PSG4 and PSGS. 
In parallel to the cosmid analyses, a lambda library was screened adopting the following strategy. 
Since the PSG cDNA insert of pSP,-i (8) contained internal BamHI cleavage sites, it was supposed 
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FIG.3. Restriction map and sequencing strategy of (A) the XPSG6/7 clone, and (B) the combined cosPSG4/5-1 
and cosPSG4/5-2 clones, whereby the boundaries of the former clone are indicated with open, and the latter 
with filled-in triangles. The following restriction endonuclease sites have been mapped: E = EcoRI, B = BamHI, 
S = SstI, SC = ScaI, Aa = AatII. For the latter two enzymes, only the sites used for mapping are shown. Filled 
in circles depict uncertain restriction sites. For Sau3a (Sa), only the sites used for sequencing are shown. The 
exons are indicated as filled-in boxes, apart from the C/3’ exon of PSG4, which has only been provisionally 
characterized (see text), and is designated as an open box. L = Leader exon, N = N-terminal exon, A, B = IgC- 
like exons A and B, C = C-terminal exon in PSG5, C/3’ = C-terminal and 3’-untranslated exon in PSG4. The 
borders of the transcription units are shown as far as they are known, and dashed lines indicate presumed 
regions, in analogy to known PSG gene borders. 
that digestion of genomic DNA clones with BamHI, followed by hybridization with pSP,-i might 
aid mapping. Of seven independent clones analysed, five contained two characteristic 
cDNA-hybridizing BamHI fragments of 0.7 and 2.3kb. Clone XPSG6/7-1 also contained an addi- 
tional cDNA-hybridizing band of 1.7kb, and was thus chosen for further analysis as containing 
potentially the most structural information. This lambda clone indeed contains sequences from two 
neighbouring PSG genes (Figure 3A). The N-terminal domain exon of the S-lying gene is not 
present within this clone and it cannot be identified with respect to known PSG genes. However, 
the high sequence similarity to other PSG genes in the corresponding repeat domain exons reveals 
its identity as a member of this gene subgroup (92-97% at the nucleotide level), rather than the 
CEA subgroup (66-78%). Furthermore, sequence comparisons of these exons with the corres- 
ponding regions for other members of the PSG subgroup reveal that they differ from all known 
sequences. For this reason, we have designated this gene PSG7, which has already been included 
in the list compiled by Barnett and Zimmermann (13). The second gene (PSG6) in this clone is 
identical in its N-terminal domain exon to the recently described hsCGM3 gene (lo), and 
corresponds to the cDNA clone XPSG6, described recently (11). 
DNA sequencing of all three clones was restricted to the whole exons and parts of their 
surrounding introns. For PSG.5, the putative promoter region was sequenced as far as 380 
nucleotides upstream from the initiator codon. The sequence data are not presented here, but 
are being forwarded to GenBank, Los Alamos, USA. 
Identification of transcripts for individual PSG genes: We have started to study the expression 
patterns of individual PSG genes, which may be expected to be coordinated, due to their tight 
linkage and strong sequence similarities. Gene-specific oligonucleotides were synthesized after 
comparing the DNA sequences from the N-terminal domains of known PSG genes or their 
transcripts (Table I). Each of these oligonucleotides should, at a high stringency, only hybridize 
with transcripts of one PSG gene. This was first calculated for each oligonucleotide according to 
Lathe (33) and confirmed for oligo PSG2 and oligo PSG4 by hybridizing them with isolated PSG 
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TABLE 1: PSG gene-specific oligonucleotide sequences. 
Name Sequence Source of sequence 
and reference 
oligo PSGl 
oligo PSGE 
oligo PSG3 
oligo PSG4 
oligo PSG5 
oligo PSG6 
5' CTAGTCCCATCATCTCCCTTTATG 3' 
5' CTCGGAAACTTTTGGTGGCTGGGC 3' 
5' TTATTTGACCATCTACTACGTATG 3' 
5' GTGACTTGGGCAGTTGTGGGCGGA 3' 
5' GTGACTTGAGCAGTGATAGGCAGG 3' 
5' AGTATAAGGTGACAGTGAAATATC 3' 
(PSG93 [4]) 
(PVG-E [911 
(SPl-i [8]) 
(XhsCGM4 [lo]) 
(cosPSG4/5) 
(XhsCGM3 [lo]) 
The corresponding cDNA/genomic clones from which they are derived are shown in brackets. 
genomic clones (data not shown). On hybridizing all these oligonucleotides with poly(A) RNA from 
placenta, transcripts for five of the genes (PSGl-5) could be identified (Figure 4A, even numbered 
lanes). Although it cannot be conclusively ruled out that one or the other oligonucleotide could 
cross-hybridize with transcripts from more than one PSG gene, the different hybridization patterns 
using the various oligonucleotides indicate a high degree of specificity for the individual probes. 
Only oligonucleotides PSG2 and PSGS show a similar hybridization signal. This is probably due to 
the fact that the corresponding transcripts are of similar sizes, as deduced from published cDNA 
data (6,9), rather than to cross-hybridization. For some of these oligonucleotides, more than one 
transcript could be visualized, e.g. for oligo PSGl, two mRNA species (Figure 4A, lane 2) and 
with oligo PSG4, three could be differentiated (Figure 4A, lane 8). Poly(A) RNA from a colon 
adenocarcinama, which could be shown to contain mRNAs for CEA (Figure 4B, lane l), was also 
hybridized, whereby no transcripts for any of the PSG genes could be identified (Figure 4A, odd 
numbered lanes). Furthermore, CEA transcripts could not be found in the placenta (Figure 4B, 
lane 2). 
Due to differences in the specific activities of the radioactively-labelled oligonucleotides, it is not 
possible to quantitate variability in expression between the different gene transcripts. However, 
A PSGl PSGP PSG3 PSG4 PSG5 PSG6 
CP CP CP CP CP cp B CEA3' 
CP 
kb 
-3.8 
-3.2 
FIG. DNA/RNA (Northern) hybridization analyses of poly(A) RNA from: (A) colon tumor ( 
numbered lanes, and 31st week placenta (P) in the even numbered lanes, hybridized at high stringency (see 
text), with the following ohgonucleotides (see Table I): oligo PSGl (lanes 1 and 2). oligo PSG2 (lanes 3 and 
4), oligo PSG3 (lanes 5 and 6). oligo PSG4 (lanes 7 and 8), oligo PSGS (lanes 9 and 10) and oligo PSG6 (lanes 
11 and 12), which are specific for the genes indicated above. (B) colon tumor (lane 1) and term placenta (lane 
2), hybridized with the RsaI/PstI fragment from the 3’-untranslated region of the pCEA3 &CIA clone &scribed 
elsewhere (11) and washed at high stringency (O.lx SSPE, 0.1% SDS, 65°C). 
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no transcript could be found in the placenta using the PSG6 gene-specific oligonucleotide, which 
as a control, did hybridize with the corresponding genomic clone XhsCGM3-l(l0) under the same 
hybridization conditions (data not shown). No gene-specific oligonucleotide was tested for PSG7. 
Determination of the transcriptional starts for two PSG genes: As a basis for studying the 
promoter regions of PSG genes in a search for common regulatory elements, we have determined 
the transcriptional start sites for the PSGl and PSGS genes. The oligonucleotide used for PSGl 
(oligo PSGl-5’) exhibited an identical hybridization pattern with term placental poly(A) RNA (data 
not shown) to the gene-specific ohgo PSGl (cf. Figure 4A, lane Z), and was used because it is 
situated closer to the transcriptional start than oligo PSGl, thus allowing a more precise determin- 
ation. Analysis of the primer extension experiments (Figure 5A) indicates multiple transcriptional 
GAC T 
B 
GACT 
FIG 5 Determination of the transcriptional start of PSGl and PSGS through: (A) primer extension analyses. 
Gngth marker, a DNA sequence reaction for PSGl was run, using the same 5’-oligonucleotide primer as 
for the PSGl primer extension reaction (see text), directly to the right. The PSGS primer extension product was 
run on the same gel and is longer, because the primer used there binds in the N-terminal region of that gene 
(see text). In both cases, the numbers shown indicate the position of the longest extension products upstream 
from the translational starts of each gene. (B) Sl nuclease analysis. As a length marker, an NCA genomic 
sequence from the 5’ region of that gene (37) was used. The sizes indicate the positions of the 5’ ends of the 
protected fragment with respect to the translational start of PSGl. The longer product visible as a band at the 
top of this lane corresponds to the 362nc DNA fragment (see text). 
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starts for both the PSGl and PSGS genes, where the longest extension products lie 130-134 
nucleotides upstream of the translational starts, in both cases. Hybridization at different 
temperatures only revealed this pattern at 45°C with oligo PSGl-5’, and above or below, these 
bands were not seen (results not shown). Using oligo PSGS, similar patterns were found up to 5O”C, 
and above no signal was visible. The shorter, strong bands at approximately -100 may represent 
alternative start sites, because their presence or absence shows an identical annealing temperature 
dependence pattern to the -130 to -134 bands at the different annealing temperatures. In contrast, 
other, smaller extension products probably represent premature termination points, due to 
secondary, structural hindrance of the reverse transcriptase, because they reveal a different 
annealing temperature dependence. The Sl nuclease assay for PSGl (Figure 5B) confirms the 
multiple starts at the same positions found with the primer extension analyses. No recognizable 
TATA box could be identified for either gene. 
DISCUSSION 
The in situ hybridization analyses with metaphase chromosomes demonstrate, unequivocally, that 
all the PSG genes are located on the long arm of chromosome 19 at position q13.2-q13.3 (Figure 
lB), close to the CEA subgroup genes, which are located at 19q13.1-13.2 (25-27). These results 
conflict with those reported elsewhere (5), which suggest that the PSG genes are located on 
chromosome 6 and the X chromosome. However, recently another group also located the PSG 
genes to chromosome 19 (38) and in parallel to our studies, a third group located these genes to 
19q13.1-13.2 (39). The close proximity of the genes within the PSG subgroup as suggested through 
the pulsed-field gel electrophoresis studies (Figure 2) has been confirmed for some of these genes 
through restriction endonuclease mapping studies, whereby it could be shown in two cases that a 
distance of only ca. 6kb separates the transcriptional units of two pairs of PSG genes (Figure 3A 
and B). The fact that this distance is conserved in the two cases analysed, along with the suggest- 
ed localization of this complete gene subgroup within an 800kb Sac11 restriction endonuclease frag- 
ment, indicates that all the PSG genes are similarly clustered. 
The existence of a gene cluster for the PSG genes, together with their strong sequence similarities 
suggests that the genes have evolved recently by unequal crossing over, which has led to gene 
multiplication. On comparing the PSG genes found here, it becomes obvious that certain rest- 
riction sites are conserved, especially in and around the exon regions. When comparing the 
restriction sites around the closely-related pairs of IgC-like exons (A, B), a stronger conservation 
between corresponding exons from different genes exists rather than between IgC-like exons within 
a gene, eg. the BamHI sites close to the A2/B2 exons are conserved in PSG7, PSG4 and PSG5 (see 
Figure 3). These sites are, however, only partially conserved in the Al/B1 exon regions of these 
genes, where intergene conservation of restriction endonuclease sites for SstI/BamHI can be found. 
Indeed this higher intergene IgC-like domain conservation is confirmed by DNA sequencing, where 
the derived amino acid sequence similarity is 90-95% for corresponding intergene repeat exons, 
but only 43-46% for internal repeat units (i.e. Al vs. A2, Bl vs. B2). Oikawa et al. (7) find similar 
results in their PSG gene, CGM35 @O-95% and 44-49%, respectively). This suggests that during 
evolution, the IgC-like exon pairs within a primordial gene duplicated prior to the whole gene unit, 
whose own duplication gave rise to new PSG genes more recently. This supplements the evolution- 
ary models which we have reported elsewhere (17,40). 
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The exon structures of all four genes characterized here are identical to those already found for 
other members of the CEA/PSG gene family (7,10,12,37,41), whereby a strong correlation exists 
between the exon and the domain borders. Interestingly, corresponding cDNA clones for PSG4, 
which have been reported elsewhere (hHSP2: [5], and XPSG4: [ll]), contain the Al, A2, B2 but 
lack the Bl repeat subdomains. We find only four nucleotide differences between the genomic 
exon sequences and the combined cDNA sequences, indicating polymorphism for this gene (data 
not shown). These exchanges lead to three amino acid exchanges. The cDNA clone FL-NCA3 (6) 
corresponds to PSGS and shows eleven nucleotide differences, leading to five amino acid 
exchanges, contains only the A2 and B2, but lacks both the Al and Bl subdomains. Recently, 
Oikawa et al. (12) have analysed the same gene. The genomic analyses for PSG4 and PSGS, show 
that the splice sites for these missing exons in PSG4 and PSGS are apparently not degenerate, as 
has been reported for another PSG gene, CGM35 (7). It is interesting to note that the Bl domains 
from PSG4 and PSGS, which are lacking in their corresponding cDNA clones hHSP2 (5) and 
FL-NCA3 (h), respectively, both contain stop codons. In the case of PSG4, this is due to a point 
mutation, whereas in PSGS, a deletion of two nucleotides, when compared with the Bl exon of 
other PSG genes, leads to a frame shift, which is followed by a stop codon. The Al exon of PSG5, 
which is missing from the corresponding cDNA clone contains an open reading frame. 
The nucleotide sequence determined downstream from the B2 exon of the PSG4 gene shows 
homology to the corresponding region region in the CGM35 gene (7). Furthermore, the con- 
servation of the first EcoRI restriction endonuclease site, downstream of the B2 exon in the 
3’-untranslated region of PSG4 (Figure 3B), with respect to the already sequenced CGM35 clone 
(7), indicates similarity to the latter further downstream. We also have provisional sequence data 
(not shown) downstream from this EcoRI site in PSG4 which confirm continued homology to the 
corresponding PSG4 cDNA (11) and the CGM35 clone (7). This whole region in CGM35 has 
been shown to contain a number of exons (7), which could be differentially spliced to give rise to 
four mRNA species, differing in their 3’untranslated regions, as shown for PSGl (11). The PSGS 
3’-untranslated region, on the other hand, appears to differ with respect to the EcoRI site, and 
indeed the nucleotide sequence diverges from the PSG4 and CGM35 sequences (7), 152 
nucleotides downstream from the 3’-end of the B2 exon (data not shown). This position coincides 
with the point of divergence between the CEA 3’untranslated region and the corresponding region 
in CGM35, as reported elsewhere (7). It was recently suggested that this divergence may have been 
caused by a deletion in the CGM35 gene and correspondingly in the PSG4 gene (11). This 
hypothesis is strengthened by the present data. We could identify the presence of a separate exon, 
downstream from B2 in PSGS through DNA sequencing, which contains coding information for the 
short C-terminal domain and the first 44 nucleotides of the 3’untranslated region, which confirms 
the model which we recently proposed (11). The rest of the 3’-untranslated region is encoded by 
at least one separate exon, which is not present within this cosmid clone, as confirmed by 
hybridization with an oligonucleotide from that region (data not shown). The 3’-untranslated region 
of PSG7 has not been analysed, but the conserved distance between PSG7 and PSG6 as compared 
to PSG4 and PSGS (Figure 3) would indicate similarity in the 3’-exon containing region to PSG4. 
In order to see whether or not these closely linked PSG genes reveal similar expression patterns, 
we have looked for individual PSG transcripts in the placenta and a colon tumor (Figure 4A), 
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whereby signals for five of six genes tested could be found in the placenta only. In a previous study, 
we were unable to detect transcripts for PSG genes in a number of tumor tissues (10). Together, 
these results indicate a high degree of tissue-specific expression. With the gene-specific oligo- 
nucleotides for PSGl and PSG4, multiple transcripts could be visualized (Figure 4A, lanes 2 and 
8). For PSGl, four mRNA splice variants have been described through cDNA cloning (4,5,9,11,14). 
A similar set of splice products can be predicted to exist for PSG4, PSG7 and CGM35 (7), which 
appear to have similar 3’-untranslated regions to PSGl (see above). For PSG2 (=PSfiG-E [9]), 
PSG3 (=SPli [8]) and PSGS, only one transcript could be found in each case (Figure 4A, lanes 
4,6 and 10). These three genes have previously been predicted, through cDNA analyses, to have 
a similar exon structure in their 3’-untranslated regions (ll), showing differences to the 
PSG4-related group. The smaller sizes of the PSG2 and PSGS mRNAs are probably due to a 
deletion, caused by alternative splicing, which has not been observed for PSG3. Although no trans- 
cript could be identified for PSGG, we have recently been able to confirm the transcriptional 
activity of this gene through the isolation of a corresponding cDNA clone (XPSGG) from a fetal 
liver cDNA library (11). No gene-specific oligonucleotides have so far been tested for PSG7. 
The coordinated expression for five of the PSG genes in a tissue-specific manner suggests that 
common regulatory elements may control their transcriptional activities. The structural organiza- 
tion of these genes within a closely linked gene cluster would facilitate such controls. Alternatively, 
there is room for individual promoters between each PSG gene (Figure 3), which may, in analogy 
to the PSG coding sequences, also be highly conserved, following the suggested recent duplication 
of complete PSG gene units (cf.40). This would in turn lead to highly similar regulation patterns. 
Closer analyses of the putative promoter regions should clarity this. 
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